Bioventus Inc.
BVSNasdaqCIK 1665988HealthcareFiscal year ends Dec 31
Reports and events: 112 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0507:43 ET | 10-Q | Quarterly reportPeriod 2026-06-27 | 0001665988-26-000042 |
| 2026-08-0507:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001665988-26-000041 |
| 2026-06-0407:54 ET | 8-K | 5.07 Shareholder vote results | 0001665988-26-000035 |
| 2026-05-2116:58 ET | 8-K | 7.01 Regulation FD disclosure | 0001665988-26-000029 |
| 2026-05-0607:48 ET | 10-Q | Quarterly reportPeriod 2026-03-28 | 0001665988-26-000027 |
| 2026-05-0607:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-26-000026 |
| 2026-04-2207:51 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001665988-26-000014 |
| 2026-03-0507:37 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001665988-26-000011 |
| 2026-03-0507:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-26-000010 |
| 2025-11-1717:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001665988-25-000032 |
| 2025-11-0407:39 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0001665988-25-000026 |
| 2025-11-0407:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-25-000025 |
| 2025-08-0607:45 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0001665988-25-000017 |
| 2025-08-0607:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001665988-25-000016 |
| 2025-08-0408:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-172192 |
| 2025-07-3108:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001665988-25-000013 |
| 2025-06-0416:16 ET | 8-K | 5.07 Shareholder vote results | 0001665988-25-000010 |
| 2025-05-0607:38 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0001628280-25-022401 |
| 2025-05-0607:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022400 |
| 2025-04-2208:10 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001628280-25-018715 |
| 2025-03-1107:42 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-011831 |
| 2025-03-1107:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-011830 |
| 2025-01-0316:09 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-000253 |
| 2024-11-0507:36 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0001628280-24-045114 |
| 2024-11-0507:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045112 |
| 2024-10-0407:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-042266 |
| 2024-08-0607:51 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0001628280-24-034979 |
| 2024-08-0607:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034976 |
| 2024-07-1916:16 ET | 8-K | 8.01 Other events | 0001193125-24-181655 |
| 2024-06-2116:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-165735 |
| 2024-06-1716:53 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-162669 |
| 2024-05-0707:36 ET | 10-Q | Quarterly reportPeriod 2024-03-30 | 0001628280-24-020846 |
| 2024-05-0707:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020843 |
| 2024-04-2607:38 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001628280-24-018431 |
| 2024-03-1207:51 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-010376 |
| 2024-03-1207:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-010371 |
| 2024-01-1908:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-010779 |
| 2024-01-1217:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-007640 |
| 2023-12-2108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-300412 |
| 2023-11-0707:40 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-037185 |
| 2023-11-0707:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037183 |
| 2023-08-0808:42 ET | 10-Q | Quarterly reportPeriod 2023-07-01 | 0001628280-23-027981 |
| 2023-08-0808:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027947 |
| 2023-06-1616:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001214659-23-008582 |
| 2023-06-0917:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-23-021758 |
| 2023-05-2608:39 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-019872 |
| 2023-05-2416:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001214659-23-007782 |
| 2023-05-1617:12 ET | 10-Q | Quarterly reportPeriod 2023-04-01 | 0001628280-23-018472 |
| 2023-05-1616:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-018425 |
| 2023-05-1608:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-145668 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.